BUECHLER KENNETH F 4

What Happened

• Kenneth F. Buechler, a director of QuidelOrtho Corporation (QDEL), was granted three awards of restricted stock units (RSUs) on June 25, 2026 totaling 31,397 RSUs (15,532; 12,204; and 3,661). Each RSU represents the right to receive one share of common stock and the RSUs were granted at $0.00 per unit (no cash purchase). The awards were issued in lieu of cash payments for director retainer/board fees under a deferred compensation program.

Key Details

• Transaction date: 2026-06-25; Filing date: 2026-06-29 (filed within the typical two-business-day Form 4 window).
• Grant amounts and unit price: 15,532 RSUs @ $0.00; 12,204 RSUs @ $0.00; 3,661 RSUs @ $0.00 (total = 31,397 RSUs).
• What the RSUs mean: Each RSU equals the right to one share on settlement (Footnote F1).
• Vesting/release notes: Awards are subject to deferred-release and vesting schedules (Footnotes F2–F4). One schedule notes a vesting on June 25, 2027 (F2); another schedule shows 3,051 shares vested 6/25/2026, with additional 3,051-share vesting on 9/25/2026, 12/25/2026 and 3/25/2027 (F4). Release of vested RSUs will follow the elected deferral schedule (F3).
• Shares owned after transaction: Not specified in the provided filing summary.

Context

• These transactions are awards/compensation (derivative RSUs), not open-market purchases or sales; they do not indicate an immediate purchase of shares nor an immediate sale of underlying stock.
• RSU awards to non-employee directors are a routine form of compensation and are often deferred, so they are generally administrative rather than a direct signal of insider sentiment.